Structure |
Chemical Name |
CAS |
MF |
|
Suvorexant Impurity 2 |
1276666-19-3 |
C23H23ClN6O2 |
|
Tenofovir impurity L |
|
|
|
Ticagrelor Impurity 27 |
1402150-01-9 |
C19H26ClN5O5S |
|
Ticagrelor impurity P |
|
|
|
Tramadol Impurity 1 |
66170-32-9 |
C16H25NO2 |
|
Lidocaine EP Impurity G |
42459-30-3 |
C13H20N2O |
|
methyl 1,4-dihydroxy-7-phenoxyisoquinoline-3-carboxylate |
1421312-32-4 |
C17H13NO5 |
|
1-(2,3-DIMETHYLPHENYL)PROPAN-1-OL |
944268-64-8 |
C11H16O |
|
4-(4-chlorophenyl)-5-methyl-3-phenylisoxazole |
1448355-87-0 |
C16H12ClNO |
|
Cefathiamidine Impurity D |
|
|
|
Cefazolin Impurity C (EP) |
|
|
|
Cefdinir Impurity H (CP) |
|
|
|
Cefdinir Impurity S(CP) |
|
|
|
Cefodizime oxidation Impurity 1 |
111874-11-4 |
C20H20N6O7S4 |
|
Spectinomycin Impurity F |
|
|
|
(7S,8R)-3-[2-(tert-butylamino)acetamido]-7-[[4-carbamoyl-2-(dimethylamino)-3,5,6-trihydroxyphenyl]methyl]-6-carboxy-5,8-dihydroxy-N,N-dimethyl-4-oxo-7,8-dihydronaphthalen-1(4H)-iminium |
|
C29H38N5O10+ |
|
3-pentylisobenzofuran-1(3H)-one |
111943-62-5 |
C13H16O2 |
|
2-[[2-2(2-Amino-4-thiazolyl)acetyl]amino]-4-thiazoleacetic Acid |
2036283-13-1 |
C10H10N4O3S2 |
|
5,11-dihydro-6H-11-ethyl-4-Methyl-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one |
133627-17-5 |
C14H14N4O |
|
(1R,3S)-1-(1,3-Benzodioxol-5-yl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic Acid Methyl Ester |
171596-44-4 |
C20H18N2O4 |
|
Amlodipine-d4 |
1185246-14-3 |
C20H25ClN2O5 |
|
Afatinib Impurity M |
|
|
|
Ornidazole Impurity |
1100750-18-2 |
|
|
4-(3-nitrophenyl)-3-Morpholinone |
845729-43-3 |
C10H10N2O4 |
|
Levofloxacin Impurity 18 |
138998-47-7 |
C14H13F4NO3 |
|
N-(5-amino-2-methylphenyl)-N-(4-(pyridin-3-yl)pyrimidin-2-yl)acetamide compound with methane (1:1) |
|
|
|
N-(2-methyl-5-(methylamino)phenyl)-N-(4-(pyridin-3-yl)pyrimidin-2-yl)formamide |
|
C18H17N5O |
|
methyl3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin -4-yl)amino)piperidin-1-yl)-3-oxopropanoate |
1616761-01-3 |
C17H23N5O3 |
|
Labetalol iMpurity |
2731858-23-2 |
|
|
ZXANKCFSGFEBQW-PFEQFJNWSA-N |
1258938-54-3 |
|
|
TWEORVZIMOFLDE-MXTNKPTQSA-N |
1706671-50-2 |
C25H31N5O9S |
|
WGEFOIHAXGTXJE-RTMVWDMESA-N |
1373171-12-0 |
C48H61NO14 |
|
ZIMIAPVHHUISPY-CLFYSBASSA-N |
866954-86-1 |
C15H15F3O5 |
|
ICOFQCJKJOISKD-HSZRJFAPSA-N |
1435768-96-9 |
C26H35NO3 |
|
Moxidectin |
119718-45-5 |
C37H53NO8 |
|
GDZISNMJFAJFMR-BEQCQUFHSA-M |
2024603-92-5 |
C58H74N2O15S |
|
GJXNGCFWGJQETE-UHFFFAOYSA-N |
1796891-27-4 |
C29H34N6O4 |
|
ethyl N-[(2,5-dichlorophenyl)carbonyl]glycinate |
328283-61-0 |
C11H11Cl2NO3 |
|
Irbesartan Impurity 4 |
945540-26-1 |
C21H20N6O |
|
BAUCJPGULMYPTE-UHFFFAOYSA-N |
2097683-67-3 |
C24H29NO4 |
|
Entecavir Impurity 6 |
1354695-82-1 |
C26H27N5O3 |
|
Bis(L-Valine) Ester Ganciclovir TFA Salt |
130914-71-5 |
C19H31N7O6 |
|
6-Chloro-6-defluoro Ciprofloxacin |
93106-58-2 |
C17H18ClN3O3 |
|
5-[(4-amino-2-carboxyphenyl)amino]-2-hydroxybenzoic acid |
1797983-23-3 |
C14H12N2O5 |
|
(S)-2-(BENZYLOXY)PROPIONAL |
81445-44-5 |
C10H12O2 |
|
1-Chloro-2-[(4-ethoxyphenyl)methyl]benzene |
1662702-90-0 |
C15H15ClO |
|
Mupirocin iMpurity F |
|
C26H44O9 |
|
Palbociclib Impurity 87 |
571189-51-0 |
C25H31N7O2 |
|
Beclometasone Impurity U |
|
|
|
Atracurium Impurity 15 Iodide(Cisatracurium Besilate EP Impurity O Iodide) |
155913-31-8 |
C38H49NO11S |
|
Vortioxetine Impurity 29 |
1928741-88-1 |
C18H23ClN2S |
|
Neratinib Impurity 12 |
544417-27-8 |
C33H37ClN6O3 |
|
Ceftriaxone Sodium impurity 2 |
|
|
|
Enrofloxacin EP Impurity E |
1369495-59-9 |
C19H22ClN3O3 |
|
147027-08-5 |
147027-08-5 |
C14H24O4S |
|
Cloxacillin EP Impurity A |
1642629-96-6 |
C19H20ClN3O6S |
|
Entacapone Impurity 7 |
1215039-66-9 |
C12H10N2O6 |
|
1,8-dibenzyl-1,4,8,11-tetraazacyclotetradecane tetrahydrochloride |
267241-20-3 |
C24H37ClN4 |
|
(3S,3'S,4R,4'R)-3,3'-(oxybis(methylene))bis(4-(4-fluorophenyl)-1- methylpiperidine) |
|
C26H34F2N2O |
|
DexMedetoMidine IMpurity 15 |
|
|
|
Canagliflozin Impurity 1 |
|
|
|
Vonoprazan Impurity 24 |
|
|
|
Esomeprazole Impurity |
|
|
|
Esomeprazole Impurity 27 |
|
|
|
Amlodipine Impurity 30 |
1089674-39-4 |
C26H31ClN2O8S |
|
Alogliptin Impurity 30 |
|
|
|
Olaparib Impurity 27 |
|
|
|
Hydrocortisone Impurity 14 |
|
C21H30O5 |
|
Teneligliptin Impurity 5 |
|
|
|
Erlotinib Hydrochloride iMpurity 54 |
|
|
|
Aciclovir EP Impurity N |
|
|
|
Vonoprazan Impurity U2 |
|
|
|
Parecoxib SodiuM iMpurity 36 |
|
|
|
phenyl (3R,4R)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4- fluorophenyl)piperidine-1-carboxylate compound |
105812-85-9 |
C26H24FNO5 |
|
Apixaban Impurity A25 |
|
|
|
Trelagliptin IMpurity 32 |
|
|
|
Afatinib Impurity 77 |
26404-20-6 |
C5H7ClO3 |
|
2a,3a,16a,17a-Diepoxy-17b-acetoxy-5a-androstane |
50588-22-2 |
C21H30O4 |
|
bis(6-(((3S,4R)-4-(4-fluorophenyl)piperidin-3-yl)methoxy)benzo[d][1,3]dioxol-5-yl)methane |
2105932-71-4 |
C39H40F2N2O6 |
|
Tenofovir Impurity 60 |
|
|
|
((3R,4S)-4-(4-fluorophenyl)-1-methylpiperidin-3-yl)methyl 4-methylbenzenesulfonate |
1258537-32-4 |
C20H24FNO3S |
|
Mupirocin Calcium EP Impurity H |
|
C26H44CaO9 |
|
Tricyclo[3.3.1.13,7]decane-1,3-diol, 5-amino- |
1382839-19-1 |
C10H17NO2 |
|
(trans)-phenyl 3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4- methoxyphenyl)piperidine-1-carboxylate |
|
C27H27NO6 |
|
Org198786-1 |
2412952-96-4 |
C71H114NNaO46S7 |
|
2-Thiazolamine, 4-(4-bromo-2-thienyl)- |
81216-89-9 |
C7H5BrN2S2 |
|
Elagolix Sodium impurity4 |
2248628-92-2 |
C19H21NO4S |
|
Tadalafil Impurity 45 |
|
|
|
(R)-3-((R)-3-(naphthalen-1-yloxy)-1-phenylpropoxy)-1-phenylpropan-1-ol |
|
C28H28O3 |
|
(trans)-4-((2-amino-4,5-dibromobenzyl)amino)cyclohexanol |
|
C13H18Br2N2O |
|
Edaravone Impurity |
|
|
|
1-Butanesulfonic acid, 4-hydroxy-, methyl ester |
343928-18-7 |
C5H12O4S |
|
Fesoterodine Impurity 17 |
|
|
|
1-(4-((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzyl)-1,4,8,11-tetraazacyclotetradecane 1-oxide |
|
C28H54N8O |
|
Cabozantinib impurity DX2 |
1628530-38-0 |
C28H24FN3O6 |
|
Selegiline Impurity (224Da) |
|
|
|
Oxybutynin Impurity(MW 481Da) |
|
|
|
Vitamin K1 hydroxylated Impurity |
|
|
|
2,2'-(4,10-bis((trans)-1,3,4-trihydroxybutan-2-yl)-1,4,7,10-tetraazacyclododecane-1,7-diyl)diacetic acid 4HCl |
|
|
|
Cefdinir CP Impurity F |
|
|